Cedars Sinai Research Updates in Lymphoma 2024

Name: Cedars Sinai Research Updates in Lymphoma 2024 - DrMedciene
SKU: MED-AMB-00814
Price: 10.00 USD
Availability: InStock

$10.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Include: 2 videos + 13 pdfs, size: 2.58 GB

SKU: MED-AMB-00814 Categories: Hematology / Oncology, Internal Medicine, Pathology courses Tags: Internal Medicine, ONCOLOGY-HEMATOLOGY, Pathology

Description

Cedars Sinai Research Updates in Lymphoma 2024

Include: 2 videos + 13 pdfs, size: 2.58 GB

Target Audience: hematologists, oncologists, internal medicine specialists, pathologists

Information:

Date & Location: Saturday, September 28, 2024, 8:30 AM – Sunday, September 29, 2024, 2:00 PM PST, Cedars-Sinai Advanced Health Science Pavilion Educational Center, Los Angeles, CA

Target Audience

Specialties – Hematology, Imaging, Internal Medicine, Oncology, Pathology & Laboratory Medicine, Radiation Oncology, Radiology, Surgery

Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Researcher (non-physician), Researcher (physician)

Overview

This conference will provide a chance for Southern California lymphoma specialists and national experts to gather and discuss updates and advancements in lymphoma treatment and research. The clinical updates sessions will highlight newly approved therapies and those in the pipeline. Case based, “How I Treat” sessions will address questions of sequencing therapies and patients selection. The scientific sessions will present high impact basic science with high translational relevance, such as new biomarkers, therapeutic targets and novel cellular therapies.

Objectives

Recognize the utility of molecular testing in the classification and treatment of lymphoma
Identify current evidence based treatments for Hodgkin lymphoma, diffuse large B-cell lymphoma, and peripheral T-cell lymphoma
Describe new treatments under development including bi-specific antibodies and CART therapies

Topics:

Genetics of Mantle Cell Lymphoma.pdf
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.pdf
Integrative genomic analysis identifies DLBCL immune environments associated with bispecific antibody response.pdf
KEYNOTE Cell Free DNA in Lymphoma.pdf
Ligand Receptor Cross talk in Hodgkin lymphoma.pdf
Mathematical modeling to generate testable hypotheses from spatial profiling data.pdf
Novel treatments for Hodgkin and T cell lymphoma.pdf
Pathology Updates What’s new with WHO classification.pdf
September 28.mp4
September 29.mp4
SUMOylation regulates T cell exhaustion in lymphoma.pdf
Transformation in CLL.pdf
Unexpected Metabolic Reprogramming in CAR-T Cells.pdf
Updates in B-cell Lymphoma.pdf
Using organoids to model follicular Lymphoma.pdf